Kanser
Kanser
Matches patients with active oncology clinical trials in Turkey using natural language search and biomarker matrices.
About
What does Kanser do?
Kanser.AI is an AI-powered clinical research matching platform designed for oncology professionals in Turkey. It enables physicians to quickly match cancer patients with active oncology clinical trials using natural language search, a universal stage and biomarker matrix, and a live data pool of current protocols. The platform aims to provide a physician-friendly decision support tool by simplifying the identification of suitable trials based on patient profiles.
What industry does Kanser operate in?
Kanser operates in HealthTech, MedTech, Clinical Trials, Oncology, Patient Matching, Natural Language Processing.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.